Brain Fogvalethealth2023-09-29T18:39:30+00:00

Do you think you have brain fog?

As women go through perimenopause and menopause, they often experience a range of symptoms, one of which is brain fog.

Brain fog is common during this life stage and can impact a person’s mental clarity, focus, and cognitive function.

Begin Brain Fog Questionnaire

Begin Brain Fog Questionnaire

1

Take our short survey to determine if some of the more common signs of brain fog may be affecting you.

Begin Brain Fog Questionnaire

If your score is 10 or more, you may be experiencing brain fog.

What is Brain Fog?

Brain fog during menopause occurs as estrogen, a crucial hormone in the female reproductive system, significantly decreases.

Estrogen helps the brain by supporting brain cells, the connections between them, and the regulation of chemicals that affect thinking and process information.
The decline in estrogen can lead to cognitive decline – brain fog.

Begin Brain Fog Questionnaire

2

If YOUR SCORE 10 OR HIGHER

Take our Health-fit online questionnaire to determine if PearlPAK™ may be right for you.

The questionnaire is a HIPAA compliant questionnaire that provides information required for our certified telehealth medical practitioners to identify if PearlPAK™ is a good fit for you.

Your responses will also allow the physician to prescribe the best AM and PM prescription combination for you.

3

AFTER THE HEALTH-FIT QUESTIONNAIRE

Continue to a FREE medical practitioner consultation.

After the health-fit questionnaire, you will be redirected to a page with insights on your questionnaire responses and next steps for a free medical practitioner consultation.

Once you click to connect with the telehealth medical practitioner, your payment information will be collected.

NO charges to your credit/debit card will be made until AFTER your appointment and commitment to a prescription.

It is important to note that PearlPAK™ is not intended to treat cognitive diseases or cognitive impairment other than brain fog during menopause. If you are experiencing significant cognitive decline or have a neurological disease, contact your physician for an evaluation.

© Copyright 2023 CleopatraRX™. All Rights Reserved. View our Privacy Policy.

*PearlPAK™️ dose system is not intended to treat neurological diseases including dementia and Alzheimer’s Disease. It is specifically designed to target cognitive difficulties in perimenopause and early menopausal women only. If you are concerned about neurological disease or have a family history of neurological disease, contact your physician.

CleopatraRX™ and PearlPAK™ are trademarks of CleopatraRX Development, LLC. CleopatraRX™ is a service mark and is used throughout this website to represent the services offered by CleopatraRX Development, LLC. PearlPAK™ is a dosage product for use as a drug/routine system and/or treatment.

The PearlPAK™️ drug/routine system is protected by U.S. Patent No. 10,369,158 – PHARMACEUTICAL PACKAGING FOR ESTRIOL THERAPY – which relates to novel packaged pharmaceutical products for the treatment of neurodegenerative diseases, such as multiple sclerosis, and methods of using these products.

Estriol Therapy U.S. Patent No. 9,962,395 – COMPOSITIONS AND METHODS FOR MAINTAINING COGNITIVE FUNCTION – Provides methods for reducing the progression of cognitive decline in a post-menopausal woman using a continuous regimen of estrogen in combination with periodic administration of a progestogen.

*PearlPAK™ dose system is not intended to treat neurological diseases including dementia and Alzheimer’s Disease. It is specifically designed to target cognitive difficulties in perimenopause and early menopausal women only. If you are concerned about neurological disease or have a family history of neurological disease, contact your physician.

CleopatraRX™ and PearlPAK™ are trademarks of CleopatraRX Development, LLC. CleopatraRX™ is a service mark and used throughout this website to represent the services offered by CleopatraRX Development, LLC. PearlPAK™ is a dosage product is for use as a drug/routine system and/or treatment.

The PearlPAK™ drug/routine system is protected by U.S. Patent No. 10,369,158 – PHARMACEUTICAL PACKAGING FOR ESTRIOL THERAPY – which relates to novel packaged pharmaceutical products for the treatment of neurodegenerative diseases, such as multiple sclerosis, and methods of using these products.

Estriol Therapy U.S. Patent No. 9,962,395 – COMPOSITIONS AND METHODS FOR MAINTAINING COGNITIVE FUNCTION – Provides methods for reducing the progression of cognitive decline in a post – menopausal woman using a continuous regimen of estrogen in combination with periodic administration of a progestogen.